AAAAAA

   
Results: 1-10 |
Results: 10

Authors: FOSTER BJ DUFFY CM SHARMA AK
Citation: Bj. Foster et al., SYSTEMIC JUVENILE RHEUMATOID-ARTHRITIS COMPLICATED BY 2 DIFFERENT RENAL LESIONS, Pediatric nephrology, 12(2), 1998, pp. 113-116

Authors: FOSTER BJ WIEGAND RA PUGH S LORUSSO PM RAKE J CORBETT TH
Citation: Bj. Foster et al., PHARMACOKINETIC STUDIES IN MICE OF 2 NEW THIOXANTHENONES (183577 AND 232759) THAT SHOWED PREFERENTIAL SOLID TUMOR-ACTIVITY, Clinical cancer research, 3(11), 1997, pp. 2047-2053

Authors: FOSTER BJ KERN JA
Citation: Bj. Foster et Ja. Kern, HER2-TARGETED GENE-TRANSFER, Human gene therapy, 8(6), 1997, pp. 719-727

Authors: FOSTER BJ JONES L WIEGAND R LORUSSO PM CORBETT TH
Citation: Bj. Foster et al., PRECLINICAL PHARMACOKINETIC, ANTITUMOR AND TOXICITY STUDIES WITH CL-994 (N-ACETYLDINALINE), Investigational new drugs, 15(3), 1997, pp. 187-194

Authors: FOSTER BJ KERN JA
Citation: Bj. Foster et Ja. Kern, RECEPTOR-MEDIATED GENE-TRANSFER TO HER2-EXPRESSING CELLS USING RHUMABHER2-POLYLYSINE-DNA COMPLEXES, Journal of investigative medicine, 44(3), 1996, pp. 318-318

Authors: FOSTER BJ WIEGAND RA LORUSSO PM BAKER LH
Citation: Bj. Foster et al., PHARMACOKINETICS OF 9-METHOXY-N, N-DIMETHYL-5-NITROPYRAZOLO [3,4,5-KL]ACRIDINE-2(6H)-PROPANAMINE (PZA, PD-115934, NSC-366140) IN MICE - GUIDELINES FOR EARLY CLINICAL-TRIALS, Clinical cancer research, 1(8), 1995, pp. 831-837

Authors: LORUSSO P FOSTER BJ POPLIN E MCCORMICK J KRAUT M FLAHERTY L HEILBRUN LK VALDIVIESO M BAKER L
Citation: P. Lorusso et al., PHASE-I CLINICAL-TRIAL OF PYRAZOLOACRIDINE NSC366140 (PD115934), Clinical cancer research, 1(12), 1995, pp. 1487-1493

Authors: MANOS P PUERNER YM FOSTER BJ BARON DA
Citation: P. Manos et al., CARBOHYDRATE ELECTROPHORESIS - THE EFFECT OF GLUCOSIDASE INHIBITORS ON THE OLIGOSACCHARIDE STRUCTURE OF THYROGLOBULIN, The FASEB journal, 9(6), 1995, pp. 1362-1362

Authors: FOSTER BJ LORUSSO PM POPLIN E ZALUPSKI M VALDIVIESO M WOZNIAK A FLAHERTY L KASUNIC DA EARHART RH BAKER LH
Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326

Authors: HODGE DJ FOSTER BJ KOMMRUSCH SJ SEARBY TJ
Citation: Dj. Hodge et al., AN 11.8-IN FLAT-PANEL DISPLAY MONITOR, HEWLETT-PAC, 46(4), 1995, pp. 51
Risultati: 1-10 |